Lifestyle after Colorectal Cancer Diagnosis in Relation to Survival and Recurrence: A Review of the Literature

Current Colorectal Cancer Reports

Volumn 13, Issue 5, 2017, Pages 370-401

  van Zutphen, Moniek ^a   Kampman, Ellen ^a   Giovannucci, Edward L ^b   van Duijnhoven, Fränzel J B ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Alcohol; Body composition; Body mass index; Colorectal cancer; Diet; Lifestyle; Physical activity; Sedentary behavior; Smoking; Survival

Indexed keywords

BEVACIZUMAB; CARBOHYDRATE; CYANOCOBALAMIN; FOLIC ACID; FRUCTOSE; METHIONINE; PYRIDOXINE; VITAMIN D;

ALCOHOL CONSUMPTION; ALL CAUSE MORTALITY; BODY COMPOSITION; BODY FAT; BODY MASS; CALCIUM INTAKE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CARBOHYDRATE INTAKE; COFFEE INTAKE; COLORECTAL CANCER; COMORBIDITY; DETERIORATION; DIET SUPPLEMENTATION; ENERGY BALANCE; EVIDENCE BASED MEDICINE; EXERCISE; FOOD INTAKE; FRUIT; FRUIT JUICE; GLYCEMIC LOAD; HUMAN; INTRAPERITONEAL FAT; LEAFY VEGETABLE; LEISURE; LIFESTYLE; MEAT INTAKE; MEDITERRANEAN DIET; MILK INTAKE; MUSCLE MASS; NUT; NUTRIENT; OBESITY; PATIENT COUNSELING; PHYSICAL ACTIVITY; PROCESSED MEAT; RED MEAT; REVIEW; RISK FACTOR; SEDENTARY LIFESTYLE; SKELETAL MUSCLE; SMOKING; SMOKING CESSATION; SUGAR-SWEETENED BEVERAGE; TEA INTAKE; TELEVISION VIEWING; UNDERWEIGHT; VITAMIN SUPPLEMENTATION; WEIGHT CHANGE; WEIGHT GAIN; WESTERN DIET; WHOLE GRAIN;

EID: 85029468533     PISSN: 15563790     EISSN: 15563804     Source Type: Journal    
DOI: 10.1007/s11888-017-0386-1     Document Type: Review

References (98)

1. World Cancer Research Fund/American Institute for Cancer Research. Continuous update project report. Food, nutrition, physical activity, and the prevention of colorectal cancer. 2011. www.wcrf.org/sites/default/files/Colorectal-Cancer-2011-Report.pdf.
2. Kushi LH, Doyle C, McCullough M, Rock CL, Demark-Wahnefried W, Bandera EV, et al. American Cancer Society guidelines on nutrition and physical activity for cancer prevention. CA Cancer J Clin. 2012;62(1):30–67. https://doi.org/10.3322/caac.20140.
3. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington DC: AICR; 2007.
4. •• Van Blarigan EL, Meyerhardt JA. Role of physical activity and diet after colorectal cancer diagnosis. J Clin Oncol. 2015. https://doi.org/10.1200/jco.2014.59.7799. This review summarizes the evidence regarding physical activity and diet after CRC diagnosis in relation to quality of life, disease recurrence, and survival.
5. Lee J, Jeon JY, Meyerhardt JA. Diet and lifestyle in survivors of colorectal cancer. Hematol Oncol Clin North Am. 2015;29(1):1–27. https://doi.org/10.1016/j.hoc.2014.09.005.
6. Schwedhelm C, Boeing H, Hoffmann G, Aleksandrova K, Schwingshackl L. Effect of diet on mortality and cancer recurrence among cancer survivors: a systematic review and meta-analysis of cohort studies. Nutr Rev. 2016;74(12):737–48. https://doi.org/10.1093/nutrit/nuw045.
7. Des Guetz G, Uzzan B, Bouillet T, Nicolas P, Chouahnia K, Zelek L, et al. Impact of physical activity on cancer-specific and overall survival of patients with colorectal cancer. Gastroenterol Res Pract. 2013;2013:340851. https://doi.org/10.1155/2013/340851.
8. Je Y, Jeon JY, Giovannucci EL, Meyerhardt JA. Association between physical activity and mortality in colorectal cancer: a meta-analysis of prospective cohort studies. International Journal of Cancer Journal international du cancer. 2013;133(8):1905–13. https://doi.org/10.1002/ijc.28208.
9. Schmid D, Leitzmann MF. Association between physical activity and mortality among breast cancer and colorectal cancer survivors: a systematic review and meta-analysis. Ann Oncol. 2014. https://doi.org/10.1093/annonc/mdu012.
10. Wu S, Liu J, Wang X, Li M, Gan Y, Tang Y. Association of obesity and overweight with overall survival in colorectal cancer patients: a meta-analysis of 29 studies. Cancer causes & control: CCC. 2014;25(11):1489–502. https://doi.org/10.1007/s10552-014-0450-y.
11. •• Friedenreich CM, Neilson HK, Farris MS, Courneya KS. Physical activity and cancer outcomes: a precision medicine approach. Clinical cancer research: an official journal of the American Association for Cancer Research. 2016;22(19):4766–75. https://doi.org/10.1158/1078-0432.ccr-16-0067. This review summarizes the epidemiologic literature relating postdiagnosis physical activity to cancer outcomes overall and by molecular/genetic subgroups.
12. Morales-Oyarvide V, Meyerhardt JA, Ng K. Vitamin D and physical activity in patients with colorectal cancer: epidemiological evidence and therapeutic implications. Cancer Journal (United States). 2016;22(3):223–31. https://doi.org/10.1097/ppo.0000000000000197.
13. •• Walter V, Jansen L, Hoffmeister M, Brenner H. Smoking and survival of colorectal cancer patients: systematic review and meta-analysis. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO. 2014;25(8):1517–25. https://doi.org/10.1093/annonc/mdu040. This systematic review and meta-analysis provides a summary of the epidemiologic literature between smoking and survival of CRC patients, including all-cause mortality, CRC-specific mortality, disease-free survival, and recurrence-free survival.
14. Sharp L, McDevitt J, Brown C, Comber H. Smoking at diagnosis significantly decreases 5-year cancer-specific survival in a population-based cohort of 18 166 colon cancer patients. Aliment Pharmacol Ther. 2017;45(6):788–800. https://doi.org/10.1111/apt.13944.
15. Parkin E, O'Reilly DA, Sherlock DJ, Manoharan P, Renehan AG. Excess adiposity and survival in patients with colorectal cancer: a systematic review. Obesity reviews: an official journal of the International Association for the Study of Obesity. 2014;15(5):434–51. https://doi.org/10.1111/obr.12140.
16. Schlesinger S, Siegert S, Koch M, Walter J, Heits N, Hinz S, et al. Postdiagnosis body mass index and risk of mortality in colorectal cancer survivors: a prospective study and meta-analysis. Cancer causes & control: CCC. 2014;25(10):1407–18. https://doi.org/10.1007/s10552-014-0435-x.
17. •• Lee J, Meyerhardt JA, Giovannucci E, Jeon JY. Association between body mass index and prognosis of colorectal cancer: a meta-analysis of prospective cohort studies. PLoS One. 2015;10(3):e0120706. https://doi.org/10.1371/journal.pone.0120706. This meta-analysis of prospective studies summarized the association of pre- and post-diagnostic BMI with CRC-specific mortality and all-cause mortality in patients with CRC.
18. Brown JC, Meyerhardt JA. Obesity and energy balance in GI cancer. J Clin Oncol. 2016;34(35):4217–24. https://doi.org/10.1200/jco.2016.66.8699.
19. Doleman B, Mills KT, Lim S, Zelhart MD, Gagliardi G. Body mass index and colorectal cancer prognosis: a systematic review and meta-analysis. Techniques in coloproctology. 2016;20(8):517–35. https://doi.org/10.1007/s10151-016-1498-3.
20. Shachar SS, Williams GR, Muss HB, Nishijima TF. Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review. Eur J Cancer. 2016;57:58–67. https://doi.org/10.1016/j.ejca.2015.12.030.
21. Xiao J, Mazurak VC, Olobatuyi TA, Caan BJ, Prado CM. Visceral adiposity and cancer survival: a review of imaging studies. European journal of cancer care. 2016. https://doi.org/10.1111/ecc.12611.
22. Malietzis G, Aziz O, Bagnall NM, Johns N, Fearon KC, Jenkins JT. The role of body composition evaluation by computerized tomography in determining colorectal cancer treatment outcomes: a systematic review. European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2015;41(2):186–96. https://doi.org/10.1016/j.ejso.2014.10.056.
23. Fung TT, Kashambwa R, Sato K, Chiuve SE, Fuchs CS, Wu K, et al. Post diagnosis diet quality and colorectal cancer survival in women. PLoS One. 2014;9(12):e115377. https://doi.org/10.1371/journal.pone.0115377.
24. Ratjen I, Schafmayer C, di Giuseppe R, Waniek S, Plachta-Danielzik S, Koch M, et al. Postdiagnostic Mediterranean and healthy Nordic dietary patterns are inversely associated with all-cause mortality in long-term colorectal cancer survivors. J Nutr. 2017;147(4):636–44. https://doi.org/10.3945/jn.116.244129.
25. Guercio BJ, Sato K, Niedzwiecki D, Ye X, Saltz LB, Mayer RJ, et al. Coffee intake, recurrence, and mortality in stage III colon cancer: results from CALGB 89803 (alliance). J Clin Oncol. 2015. https://doi.org/10.1200/jco.2015.61.5062.
26. Tamakoshi A, Nakamura K, Ukawa S, Okada E, Hirata M, Nagai A, et al. Characteristics and prognosis of Japanese colorectal cancer patients: the BioBank Japan project. Journal of epidemiology. 2017;27(3):S36–42. https://doi.org/10.1016/j.je.2016.12.004.
27. Yang B, Gapstur SM, Newton CC, Jacobs EJ, Campbell PT. Alcohol intake and mortality among survivors of colorectal cancer: the Cancer Prevention Study II Nutrition Cohort. Cancer. 2017. https://doi.org/10.1002/cncr.30556.
28. Tao L, Wang R, Gao YT, Yuan JM. Impact of postdiagnosis smoking on long-term survival of cancer patients: the Shanghai Cohort Study. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2013;22(12):2404–11. https://doi.org/10.1158/1055-9965.epi-13-0805-t.
29. Yang B, Jacobs EJ, Gapstur SM, Stevens V, Campbell PT. Active smoking and mortality among colorectal cancer survivors: the Cancer Prevention Study II nutrition cohort. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2015;33(8):885–93. https://doi.org/10.1200/jco.2014.58.3831.
30. Sharp L, McDevitt J, Brown C, Carsin AE, Comber H. Association between smoking at diagnosis and cause-specific survival in patients with rectal cancer: results from a population-based analysis of 10,794 cases. Cancer. 2017. https://doi.org/10.1002/cncr.30583.
31. Rasouli MA, Moradi G, Roshani D, Nikkhoo B, Ghaderi E, Ghaytasi B. Prognostic factors and survival of colorectal cancer in Kurdistan province, Iran: a population-based study (2009-2014). Medicine. 2017;96(6):e5941. https://doi.org/10.1097/md.0000000000005941.
32. Kroenke CH, Neugebauer R, Meyerhardt J, Prado CM, Weltzien E, Kwan ML, et al. Analysis of body mass index and mortality in patients with colorectal cancer using causal diagrams. JAMA Oncol. 2016;2(9):1137–45. https://doi.org/10.1001/jamaoncol.2016.0732.
33. Walter V, Jansen L, Hoffmeister M, Ulrich A, Roth W, Bläker H, et al. Prognostic relevance of prediagnostic weight loss and overweight at diagnosis in patients with colorectal cancer. Am J Clin Nutr. 2016;104(4):1110–20. https://doi.org/10.3945/ajcn.116.136531.
34. Patel GS, Ullah S, Beeke C, Hakendorf P, Padbury R, Price TJ, et al. Association of BMI with overall survival in patients with mCRC who received chemotherapy versus EGFR and VEGF-targeted therapies. Cancer Medicine. 2015;4(10):1461–71. https://doi.org/10.1002/cam4.490.
35. Black D, Mackay C, Ramsay G, Hamoodi Z, Nanthakumaran S, Park KGM, et al. Prognostic value of computed tomography: measured parameters of body composition in primary operable gastrointestinal cancers. Ann Surg Oncol. 2017:1–11. https://doi.org/10.1245/s10434-017-5829-z.
36. Blauwhoff-Buskermolen S, Versteeg KS, de van der Schueren MA, den Braver NR, Berkhof J, Langius JA, et al. Loss of muscle mass during chemotherapy is predictive for poor survival of patients with metastatic colorectal cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2016;34(12):1339–44. https://doi.org/10.1200/JCO.2015.63.6043.
37. Jung HW, Kim JW, Kim JY, Kim SW, Yang HK, Lee JW, et al. Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy. Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer. 2015;23(3):687–94. https://doi.org/10.1007/s00520-014-2418-6.
38. Malietzis G, Currie AC, Athanasiou T, Johns N, Anyamene N, Glynne-Jones R, et al. Influence of body composition profile on outcomes following colorectal cancer surgery. Br J Surg. 2016;103(5):572–80. https://doi.org/10.1002/bjs.10075.
39. •• Caan BJ, Meyerhardt JA, Kroenke CH, Alexeeff S, Xiao J, Weltzien E, et al. Explaining the obesity paradox: the association between body composition and colorectal cancer survival (C-SCANS study). Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2017. https://doi.org/10.1158/1055-9965.EPI-17-0200. This study among non-metastatic CRC patients concluded that body composition appeared to explain why a BMI higher than normal is associated with the lowest mortality risk and therefore they refute the notion that the association between overweight and lower mortality is solely due to methodologic biases.
40. McCullough ML, Gapstur SM, Shah R, Jacobs EJ, Campbell PT. Association between red and processed meat intake and mortality among colorectal cancer survivors. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2013;31(22):2773–82. https://doi.org/10.1200/JCO.2013.49.1126.
41. Yang B, McCullough ML, Gapstur SM, Jacobs EJ, Bostick RM, Fedirko V, et al. Calcium, vitamin D, dairy products, and mortality among colorectal cancer survivors: the Cancer Prevention Study-II Nutrition Cohort. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2014;32(22):2335–43. https://doi.org/10.1200/JCO.2014.55.3024.
42. Meyerhardt JA, Niedzwiecki D, Hollis D, Saltz LB, Hu FB, Mayer RJ, et al. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA: the journal of the American Medical Association. 2007;298(7):754–64. https://doi.org/10.1001/jama.298.7.754.
43. Fuchs MA, Sato K, Niedzwiecki D, Ye X, Saltz LB, Mayer RJ, et al. Sugar-sweetened beverage intake and cancer recurrence and survival in CALGB 89803 (alliance). PLoS One. 2014;9(6):e99816. https://doi.org/10.1371/journal.pone.0099816.
44. Lochhead P, Nishihara R, Qian ZR, Mima K, Cao Y, Sukawa Y, et al. Postdiagnostic intake of one-carbon nutrients and alcohol in relation to colorectal cancer survival. Am J Clin Nutr. 2015;102(5):1134–41. https://doi.org/10.3945/ajcn.115.115162.
45. Meyerhardt JA, Sato K, Niedzwiecki D, Ye C, Saltz LB, Mayer RJ, et al. Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Natl Cancer Inst. 2012;104(22):1702–11. https://doi.org/10.1093/jnci/djs399.
46. Meyerhardt JA, Giovannucci EL, Holmes MD, Chan AT, Chan JA, Colditz GA, et al. Physical activity and survival after colorectal cancer diagnosis. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2006;24(22):3527–34. https://doi.org/10.1200/JCO.2006.06.0855.
47. Meyerhardt JA, Giovannucci EL, Ogino S, Kirkner GJ, Chan AT, Willett W, et al. Physical activity and male colorectal cancer survival. Arch Intern Med. 2009;169(22):2102–8. https://doi.org/10.1001/archinternmed.2009.412.
48. Baade PD, Meng X, Youl PH, Aitken JF, Dunn J, Chambers SK. The impact of body mass index and physical activity on mortality among patients with colorectal cancer in Queensland, Australia. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2011;20(7):1410–20. https://doi.org/10.1158/1055-9965.EPI-11-0079.
49. Kuiper JG, Phipps AI, Neuhouser ML, Chlebowski RT, Thomson CA, Irwin ML, et al. Recreational physical activity, body mass index, and survival in women with colorectal cancer. Cancer causes & control: CCC. 2012;23(12):1939–48. https://doi.org/10.1007/s10552-012-0071-2.
50. Campbell PT, Patel AV, Newton CC, Jacobs EJ, Gapstur SM. Associations of recreational physical activity and leisure time spent sitting with colorectal cancer survival. J Clin Oncol. 2013;31(7):876–85. https://doi.org/10.1200/jco.2012.45.9735.
51. Arem H, Pfeiffer RM, Engels EA, Alfano CM, Hollenbeck A, Park Y, et al. Pre- and postdiagnosis physical activity, television viewing, and mortality among patients with colorectal cancer in the National Institutes of Health-AARP diet and health study. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2015;33(2):180–8. https://doi.org/10.1200/JCO.2014.58.1355.
52. Meyerhardt JA, Heseltine D, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, et al. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2006;24(22):3535–41. https://doi.org/10.1200/JCO.2006.06.0863.
53. Cao Y, Meyerhardt JA, Chan AT, Wu K, Fuchs CS, Giovannucci EL. Television watching and colorectal cancer survival in men. Cancer Causes Control. 2015;26(10):1467–76. https://doi.org/10.1007/s10552-015-0645-x.
54. Jadallah F, McCall JL, van Rij AM. Recurrence and survival after potentially curative surgery for colorectal cancer. The New Zealand medical journal. 1999;112(1091):248–50.
55. Ali RA, Dooley C, Comber H, Newell J, Egan LJ. Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association. 2011;9(7):584-9.e1–2. https://doi.org/10.1016/j.cgh.2011.04.016.
56. Warren GW, Kasza KA, Reid ME, Cummings KM, Marshall JR. Smoking at diagnosis and survival in cancer patients. International journal of cancer Journal international du cancer. 2013;132(2):401–10. https://doi.org/10.1002/ijc.27617.
57. Amri R, Bordeianou LG, Sylla P, Berger DL. Does active smoking induce hematogenous metastatic spread in colon cancer? Am J Surg. 2015;210(5):930–2. https://doi.org/10.1016/j.amjsurg.2015.03.034.
58. Walter V, Jansen L, Hoffmeister M, Ulrich A, Chang-Claude J, Brenner H. Smoking and survival of colorectal cancer patients: population-based study from Germany. International journal of cancer Journal international du cancer. 2015;137(6):1433–45. https://doi.org/10.1002/ijc.29511.
59. Munro AJ, Bentley AH, Ackland C, Boyle PJ. Smoking compromises cause-specific survival in patients with operable colorectal cancer. Clin Oncol (R Coll Radiol). 2006;18(6):436–40.
60. McCleary NJ, Niedzwiecki D, Hollis D, Saltz LB, Schaefer P, Whittom R, et al. Impact of smoking on patients with stage III colon cancer: results from cancer and leukemia group B 89803. Cancer. 2010;116(4):957–66. https://doi.org/10.1002/cncr.24866.
61. Phipps AI, Shi Q, Newcomb PA, Nelson GD, Sargent DJ, Alberts SR, et al. Associations between cigarette smoking status and colon cancer prognosis among participants in north central cancer treatment group phase III trial N0147. J Clin Oncol. 2013;31(16):2016–23. https://doi.org/10.1200/JCO.2012.46.2457.
62. Asghari-Jafarabadi M, Hajizadeh E, Kazemnejad A, Fatemi SR. Site-specific evaluation of prognostic factors on survival in Iranian colorectal cancer patients: a competing risks survival analysis. Asian Pacific journal of cancer prevention: APJCP. 2009;10(5):815–21.
63. Hines RB, Shanmugam C, Waterbor JW, McGwin G Jr, Funkhouser E, Coffey CS, et al. Effect of comorbidity and body mass index on the survival of African-American and Caucasian patients with colon cancer. Cancer. 2009;115(24):5798–806. https://doi.org/10.1002/cncr.24598.
64. Campbell PT, Newton CC, Dehal AN, Jacobs EJ, Patel AV, Gapstur SM. Impact of body mass index on survival after colorectal cancer diagnosis: the cancer prevention study-II nutrition cohort. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2012;30(1):42–52. https://doi.org/10.1200/JCO.2011.38.0287.
65. Chin CC, Kuo YH, Yeh CY, Chen JS, Tang R, Changchien CR, et al. Role of body mass index in colon cancer patients in Taiwan. World journal of gastroenterology: WJG. 2012;18(31):4191–8. https://doi.org/10.3748/wjg.v18.i31.4191.
66. Alipour S, Kennecke HF, Woods R, Lim HJ, Speers C, Brown CJ, et al. Body mass index and body surface area and their associations with outcomes in stage II and III colon cancer. J Gastrointest Cancer. 2013;44(2):203–10. https://doi.org/10.1007/s12029-012-9472-4.
67. Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Benson AB 3rd, Macdonald JS, et al. Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer. 2003;98(3):484–95. https://doi.org/10.1002/cncr.11544.
68. Meyerhardt JA, Tepper JE, Niedzwiecki D, Hollis DR, McCollum AD, Brady D, et al. Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from intergroup trial 0114. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2004;22(4):648–57. https://doi.org/10.1200/JCO.2004.07.121.
69. Sinicrope FA, Foster NR, Yothers G, Benson A, Seitz JF, Labianca R, et al. Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy. Cancer. 2013;119(8):1528–36. https://doi.org/10.1002/cncr.27938.
70. Renfro LA, Loupakis F, Adams RA, Seymour MT, Heinemann V, Schmoll HJ, et al. Body mass index is prognostic in metastatic colorectal cancer: pooled analysis of patients from first-line clinical trials in the ARCAD database. J Clin Oncol. 2016;34(2):144–50. https://doi.org/10.1200/jco.2015.61.6441.
71. Rickles AS, Iannuzzi JC, Mironov O, Deeb AP, Sharma A, Fleming FJ, et al. Visceral obesity and colorectal cancer: are we missing the boat with BMI? Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract. 2013;17(1):133–143; discussion p 43. https://doi.org/10.1007/s11605-012-2045-9.
72. Clark W, Siegel EM, Chen YA, Zhao X, Parsons CM, Hernandez JM, et al. Quantitative measures of visceral adiposity and body mass index in predicting rectal cancer outcomes after neoadjuvant chemoradiation. J Am Coll Surg. 2013;216(6):1070–81. https://doi.org/10.1016/j.jamcollsurg.2013.01.007.
73. Lee CS, Murphy DJ, McMahon C, Nolan B, Cullen G, Mulcahy H, et al. Visceral adiposity is a risk factor for poor prognosis in colorectal cancer patients receiving adjuvant chemotherapy. Journal of Gastrointestinal Cancer. 2015;46(3):243–50. https://doi.org/10.1007/s12029-015-9709-0.
74. Guiu B, Petit JM, Bonnetain F, Ladoire S, Guiu S, Cercueil JP, et al. Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer. Gut. 2010;59(3):341–7. https://doi.org/10.1136/gut.2009.188946.
75. Miyamoto Y, Baba Y, Sakamoto Y, Ohuchi M, Tokunaga R, Kurashige J, et al. Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer. Ann Surg Oncol. 2015;22(8):2663–8. https://doi.org/10.1245/s10434-014-4281-6.
76. van Vledder MG, Levolger S, Ayez N, Verhoef C, Tran TC, Ijzermans JN. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg. 2012;99(4):550–7. https://doi.org/10.1002/bjs.7823.
77. Thoresen L, Frykholm G, Lydersen S, Ulveland H, Baracos V, Prado CM, et al. Nutritional status, cachexia and survival in patients with advanced colorectal carcinoma. Different assessment criteria for nutritional status provide unequal results. Clin Nutr. 2013;32(1):65–72. https://doi.org/10.1016/j.clnu.2012.05.009.
78. Ravasco P, Monteiro-Grillo I, Camilo M. Individualized nutrition intervention is of major benefit to colorectal cancer patients: long-term follow-up of a randomized controlled trial of nutritional therapy. Am J Clin Nutr. 2012;96(6):1346–53. https://doi.org/10.3945/ajcn.111.018838.
79. Phipps AI, Baron J, Newcomb PA. Prediagnostic smoking history, alcohol consumption, and colorectal cancer survival: the Seattle colon cancer family registry. Cancer. 2011;117(21):4948–57. https://doi.org/10.1002/cncr.26114.
80. Meyerhardt JA, Kroenke CH, Prado CM, Kwan ML, Castillo A, Weltzien E, et al. Association of Weight Change after colorectal cancer diagnosis and outcomes in the Kaiser Permanente northern California population. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2016;26(1):30–7. https://doi.org/10.1158/1055-9965.EPI-16-0145.
81. Meyerhardt JA, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Nelson H, et al. Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from cancer and leukemia group B 89803. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2008;26(25):4109–15. https://doi.org/10.1200/JCO.2007.15.6687.
82. Vergidis J, Gresham G, Lim HJ, Renouf DJ, Kennecke HF, Ruan JY, et al. Impact of weight changes after the diagnosis of stage III colon cancer on survival outcomes. Clin Colorectal Cancer. 2016;15(1):16–23. https://doi.org/10.1016/j.clcc.2015.07.002.
83. Courneya KS, Booth CM, Gill S, O'Brien P, Vardy J, Friedenreich CM, et al. The colon health and life-long exercise change trial: a randomized trial of the National Cancer Institute of Canada clinical trials group. Curr Oncol. 2008;15(6):279–85.
84. Australian Gastro-Intestinal Trials Group. CHALLENGE clinical trial. https://agitg.org.au/challenge-clinical-trial/. 2017. Accessed 7 August 2017.
85. Courneya KS, Vardy JL, O'Callaghan CJ, Friedenreich CM, Campbell KL, Prapavessis H, et al. Effects of a structured exercise program on physical activity and fitness in colon cancer survivors: one year feasibility results from the CHALLENGE trial. Cancer Epidemiol Biomark Prev. 2016;25(6):969–77. https://doi.org/10.1158/1055-9965.epi-15-1267.
86. •• Moug SJ, Bryce A, Mutrie N, Anderson AS. Lifestyle interventions are feasible in patients with colorectal cancer with potential short-term health benefits: a systematic review. Int J Color Dis. 2017;32(6):765–75. https://doi.org/10.1007/s00384-017-2797-5. This systematic review assessed the evidence for the feasibility of performing lifestyle interventions in CRC patients and evaluated any short- and long-term health benefits.
87. Lennon H, Sperrin M, Badrick E, Renehan AG. The obesity paradox in cancer: a review. Curr Oncol Rep. 2016;18(9):56. https://doi.org/10.1007/s11912-016-0539-4.
88. Shuster A, Patlas M, Pinthus JH, Mourtzakis M. The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol. 2012;85(1009):1–10. https://doi.org/10.1259/bjr/38447238.
89. Feliciano EMC, Kroenke CH, Meyerhardt JA, Prado CM, Bradshaw PT, Dannenberg AJ, et al. Metabolic dysfunction, obesity, and survival among patients with early-stage colorectal cancer. J Clin Oncol. 2016;34(30):3664–71. https://doi.org/10.1200/jco.2016.67.4473.
90. Vrieling A, Kampman E. The role of body mass index, physical activity, and diet in colorectal cancer recurrence and survival: a review of the literature. Am J Clin Nutr. 2010;92(3):471–90. https://doi.org/10.3945/ajcn.2010.29005.
91. Inoue-Choi M, Robien K, Lazovich D. Adherence to the WCRF/AICR guidelines for cancer prevention is associated with lower mortality among older female cancer survivors. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2013;22(5):792–802. https://doi.org/10.1158/1055-9965.EPI-13-0054.
92. Winkels RM, Heine-Broring RC, van Zutphen M, van Harten-Gerritsen S, Kok DE, van Duijnhoven FJ, et al. The COLON study: colorectal cancer: longitudinal, observational study on nutritional and lifestyle factors that may influence colorectal tumour recurrence, survival and quality of life. BMC Cancer. 2014;14(1):374. https://doi.org/10.1186/1471-2407-14-374.
93. Soares-Miranda L, Abreu S, Silva M, Peixoto A, Ramalho R, da Silva PC, et al. Cancer survivor study (CASUS) on colorectal patients: longitudinal study on physical activity, fitness, nutrition, and its influences on quality of life, disease recurrence, and survival. Rationale and design. Int J Color Dis. 2016. https://doi.org/10.1007/s00384-016-2671-x.
94. van Roekel EH, Bours MJL, de Brouwer CPM, Ten Napel H, Sanduleanu S, Beets GL, et al. The applicability of the international classification of functioning, disability, and health to study lifestyle and quality of life of colorectal cancer survivors. Cancer Epidemiol Biomark Prev. 2014;23(7):1394–405. https://doi.org/10.1158/1055-9965.epi-13-1144.
95. Punt CJA, Buyse M, Köhne C-H, Hohenberger P, Labianca R, Schmoll HJ, et al. Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials. J Natl Cancer Inst. 2007;99(13):998–1003. https://doi.org/10.1093/jnci/djm024.
96. Hawkes AL, Lynch BM, Owen N, Aitken JF. Lifestyle factors associated concurrently and prospectively with co-morbid cardiovascular disease in a population-based cohort of colorectal cancer survivors. Eur J Cancer. 2011;47(2):267–76. https://doi.org/10.1016/j.ejca.2010.10.002.
97. Vigneri PG, Tirro E, Pennisi MS, Massimino M, Stella S, Romano C, et al. The insulin/IGF system in colorectal cancer development and resistance to therapy. Front Oncol. 2015;5:230. https://doi.org/10.3389/fonc.2015.00230.
98. Keum N, Yuan C, Nishihara R, Zoltick E, Hamada T, Martinez Fernandez A, et al. Dietary glycemic and insulin scores and colorectal cancer survival by tumor molecular biomarkers. Int J Cancer. 2017;140(12):2648–56. https://doi.org/10.1002/ijc.30683.